U.S. FDA issues VAI classification to Natco Pharma’s FDF unit in Vizag
VAI is one of the three classifications, the U.S. FDA issues implying objectionable conditions or practices were found, during the inspection, but the regulator is not prepared to take or recommend any administrative or regulatory action

Read at The Hindu(opens in a new tab)
Full coverage
U.S. FDA issues VAI classification to Natco Pharma’s FDF unit in Vizag (opens The Hindu in a new tab)
VAI is one of the three classifications, the U.S. FDA issues implying objectionable conditions or practices were found, during the inspection, but the regulator is not prepared to take or recommend any administrative or regulatory action
